1. Left atrial appendage closure with the watchman device reduces atrial fibrillation management costs
- Author
-
Joachim Kugler, Steffen Behrens, Denise Weber, Jasmin Ortak, Erdal Safak, Fatih Arslan, Harald Darius, Stephan Kische, Giuseppe D Ancona, Hüseyin Ince, and Dietlind Zohlenhöfer-Momm
- Subjects
Male ,medicine.medical_specialty ,Cardiac Catheterization ,Percutaneous ,Risk profile ,Left atrial ,Internal medicine ,Germany ,Atrial Fibrillation ,Medicine ,Humans ,Atrial Appendage ,Aged ,Fibrillation ,business.industry ,Atrial fibrillation ,General Medicine ,Prostheses and Implants ,medicine.disease ,Hospitalization ,Median time ,Hospitalization cost ,Cardiology ,Costs and Cost Analysis ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
To report hospitalization costs of patients with non-valvular atrial fibrillation (AF) submitted to percutaneous left atrial appendage closure (LAAC) with the Watchman device. Pre- and post-procedural hospitalization AF-related costs were calculated using the DRG system (diagnosis-related groups) and compared. Between 2012 and 2016, 677 non-valvular AF patients underwent LAAC. Median time from first cardiac hospitalization to LAAC was 5.9 years (IQR 1.6–9.1) and median follow-up after LAAC was 4.8 years (IQR 3.6–5.6). LAAC mortality was 1.3% and follow-up mortality 16.9%. Median pre-LAAC hospitalization cost was € 17,867 (IQR € 7512–35,08) and post-LAAC € 8772 (IQR € 1183–25,159) (p
- Published
- 2020